Clinical Trial Update: Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension [Phase 3]

View source ↗

Summary

Phase III randomized trial evaluating UT-15 in patients with pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• UT-15

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED